• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I型原发性高草酸尿症

Primary hyperoxaluria type I.

作者信息

Latta K, Brodehl J

机构信息

Kinderklinik der Medizinischen Hochschule, Abteilung für pädiatrische Nephrologie und Stoffwechselkrankheiten, Hannover, Federal Republic of Germany.

出版信息

Eur J Pediatr. 1990 May;149(8):518-22. doi: 10.1007/BF01957682.

DOI:10.1007/BF01957682
PMID:2189732
Abstract

Primary hyperoxaluria type I is a metabolic disorder caused by the deficiency of the peroxisomal alanine:glyoxylate aminotransferase. The disease is inherited as an autosomal recessive trait. The clinical course is outlined based on data from 330 published cases. Diagnostic cornerstones are clinical parameters, urinary excretion of oxalate and glycolate, and the determination of enzyme activity in liver tissue. Principles of conservative treatment, e.g. volume load and pyridoxine substitution, are described as well as experience with different modes of dialysis and transplantation. Kidney transplantation is associated with a high rate of recurrence of the original disease despite excellent management resulting in many instances in early graft loss. Liver transplantation offers the possibility to correct the metabolic defect and to prevent the progression of crystal deposition in the body.

摘要

I型原发性高草酸尿症是一种由过氧化物酶体丙氨酸:乙醛酸氨基转移酶缺乏引起的代谢紊乱疾病。该疾病以常染色体隐性特征遗传。根据330例已发表病例的数据概述了其临床病程。诊断的关键依据是临床参数、尿液中草酸盐和乙醇酸盐的排泄情况以及肝组织中酶活性的测定。文中描述了保守治疗的原则,如容量负荷和维生素B6替代疗法,以及不同透析和移植方式的经验。尽管管理出色,但肾移植仍伴随着原发病的高复发率,在许多情况下导致早期移植肾丢失。肝移植为纠正代谢缺陷和防止体内晶体沉积的进展提供了可能。

相似文献

1
Primary hyperoxaluria type I.I型原发性高草酸尿症
Eur J Pediatr. 1990 May;149(8):518-22. doi: 10.1007/BF01957682.
2
[Primary hyperoxaluria].[原发性高草酸尿症]
Nephrol Ther. 2011 Jul;7(4):249-59. doi: 10.1016/j.nephro.2011.03.004. Epub 2011 Jun 2.
3
[Primary hyperoxaluria: A review].[原发性高草酸尿症:综述]
Nephrol Ther. 2016 Nov;12(6):431-436. doi: 10.1016/j.nephro.2016.03.005. Epub 2016 Jun 29.
4
Combined liver-kidney transplantation in primary hyperoxaluria type 1.1型原发性高草酸尿症的肝肾联合移植
Eur J Pediatr. 1999 Dec;158 Suppl 2:S75-80. doi: 10.1007/pl00014327.
5
[Primary hyperoxaluria].[原发性高草酸尿症]
Ugeskr Laeger. 1989 Jul 17;151(29):1856-9.
6
Successful treatment of primary hyperoxaluria type I by combined hepatic and renal transplantation.
Lancet. 1987 Aug 29;2(8557):474-5. doi: 10.1016/s0140-6736(87)91791-0.
7
Fetal liver alanine: glyoxylate aminotransferase and the prenatal diagnosis of primary hyperoxaluria type 1.胎儿肝脏丙氨酸:乙醛酸转氨酶与1型原发性高草酸尿症的产前诊断
Prenat Diagn. 1989 Apr;9(4):271-81. doi: 10.1002/pd.1970090406.
8
Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria.1 型高草酸尿症患者的夜间家庭血液透析。
Am J Kidney Dis. 2013 Dec;62(6):1155-9. doi: 10.1053/j.ajkd.2013.05.013. Epub 2013 Jul 4.
9
[Primary hyperoxaluria].[原发性高草酸尿症]
Nephrologie. 1995;16(6):399-406.
10
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment.Ⅰ型原发性高草酸尿症:筛查指征和诊断及治疗指导。
Nephrol Dial Transplant. 2012 May;27(5):1729-36. doi: 10.1093/ndt/gfs078.

引用本文的文献

1
Improving Treatment Options for Primary Hyperoxaluria.改善原发性高草酸尿症的治疗选择。
Drugs. 2022 Jul;82(10):1077-1094. doi: 10.1007/s40265-022-01735-x. Epub 2022 Jul 2.
2
Primary hyperoxaluria Type 1: A case report in an extended family with a novel AGXT gene mutation.1型原发性高草酸尿症:一个具有新型AGXT基因突变的大家庭中的病例报告
Medicine (Baltimore). 2020 Jun 19;99(25):e20371. doi: 10.1097/MD.0000000000020371.
3
A Successful Approach to Kidney Transplantation in Patients With Enteric (Secondary) Hyperoxaluria.肠道(继发性)高草酸尿症患者肾移植的成功方法

本文引用的文献

1
Further observations on the genetic basis of primary hyperoxaluria.关于原发性高草酸尿症遗传基础的进一步观察
Ann Hum Genet. 1959 Dec;23:367-81. doi: 10.1111/j.1469-1809.1959.tb01480.x.
2
PRIMARY HYPEROXALURIA.原发性高草酸尿症
Medicine (Baltimore). 1964 May;43:315-45. doi: 10.1097/00005792-196405000-00010.
3
Primary hyperoxaluria.
Lancet. 1957 Aug 17;273(6990):320-2. doi: 10.1016/s0140-6736(57)92210-9.
Transplant Direct. 2017 Nov 8;3(12):e331. doi: 10.1097/TXD.0000000000000748. eCollection 2017 Dec.
4
Primary Hyperoxaluria Type 1 with Homozygosity for a Double-mutated Allele in a 2-year-old Child.一名2岁儿童因双突变等位基因纯合导致1型原发性高草酸尿症
Indian J Nephrol. 2017 Sep-Oct;27(5):402-405. doi: 10.4103/ijn.IJN_261_16.
5
Unusual clinical outcome of primary Hyperoxaluria type 1 in Tunisian patients carrying 33_34InsC mutation.携带33_34InsC突变的突尼斯患者1型原发性高草酸尿症的异常临床结局
BMC Nephrol. 2017 Jun 15;18(1):195. doi: 10.1186/s12882-017-0612-8.
6
Mutational analysis of AGXT in two Chinese families with primary hyperoxaluria type 1.AGXT 基因突变分析在两例中国人原发性高草酸尿症 1 型家系中的研究
BMC Nephrol. 2014 Jun 17;15:92. doi: 10.1186/1471-2369-15-92.
7
An update on primary hyperoxaluria.原发性高草酸尿症的最新进展。
Nat Rev Nephrol. 2012 Jun 12;8(8):467-75. doi: 10.1038/nrneph.2012.113.
8
The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases.改善加速审批获得途径对低流行罕见病治疗开发的潜在投资影响。
Orphanet J Rare Dis. 2011 Jul 6;6:49. doi: 10.1186/1750-1172-6-49.
9
Selected AGXT gene mutations analysis provides a genetic diagnosis in 28% of Tunisian patients with primary hyperoxaluria.28%的原发性高草酸尿症突尼斯患者通过分析选定的 AGXT 基因突变可做出基因诊断。
BMC Nephrol. 2011 May 25;12:25. doi: 10.1186/1471-2369-12-25.
10
Studies on a unique organelle localization of a liver enzyme, serine:pyruvate (or alanine:glyoxylate) aminotransferase.研究一种肝脏酶——丝氨酸:丙酮酸(或丙氨酸:乙醛酸)氨基转移酶的独特细胞器定位。
Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(5):274-86. doi: 10.2183/pjab.87.274.
4
Ophthalmic manifestations of primary oxalosis.原发性草酸盐沉着症的眼部表现。
Br J Ophthalmol. 1980 Oct;64(10):782-8. doi: 10.1136/bjo.64.10.782.
5
Ultrasonic diagnosis of primary hyperoxaluria in infancy.
Radiology. 1982 Oct;145(1):147-8. doi: 10.1148/radiology.145.1.7122872.
6
Calcium-oxalate-crystal-induced bone disease.
Am J Kidney Dis. 1982 Mar;1(5):294-9. doi: 10.1016/s0272-6386(82)80028-0.
7
Oxalosis-induced bone disease: a complication of transplantation and prolonged survival in primary hyperoxaluria.
J Bone Joint Surg Am. 1981 Feb;63(2):310-6.
8
Bone changes in end-stage oxalosis.
AJR Am J Roentgenol. 1981 May;136(5):935-9. doi: 10.2214/ajr.136.5.935.
9
Pancytopenia and hepatosplenomegaly in oxalosis.
Arch Intern Med. 1984 Jan;144(1):167-8.
10
Pyridoxine treatment of type 1 hyperoxaluria.维生素B6治疗1型高草酸尿症。
N Engl J Med. 1984 Sep 20;311(12):798-9.